Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950136-07-006575
Filing Date
2007-09-24
Accepted
2007-09-24 09:24:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 file1.htm S-3/A 544426
2 CONSENT file2.htm EX-23.2 3967
3 ebox.gif GRAPHIC 58
4 spacer.gif GRAPHIC 43
5 cbox.gif GRAPHIC 61
6 html_protalixlogo.jpg GRAPHIC 19177
7 html_06226logo.jpg GRAPHIC 10156
  Complete submission text file 0000950136-07-006575.txt   591279
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-144801 | Film No.: 071130602
SIC: 2836 Biological Products, (No Diagnostic Substances)